Carregant...
Metastatic hormone-sensitive prostate cancer: How should it be treated?
The number of treatment options for metastatic hormone-sensitive prostate cancer has increased substantially in recent years. The classic treatment approach for these patients—androgen-deprivation therapy alone—is now considered suboptimal. Several randomized phase III clinical trials have demonstra...
Guardat en:
| Publicat a: | World J Clin Oncol |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Baishideng Publishing Group Inc
2021
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7918528/ https://ncbi.nlm.nih.gov/pubmed/33680871 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5306/wjco.v12.i2.43 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|